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Abstract
Introduction: Haemorrhagic shock is associated with an inflammatory response consecutive to ischaemia-reperfusion
(I/R) that leads to cardiovascular failure and organ injury. The role of and the timing of administration of hydrogen
sulphide (H2S) remain uncertain. Vascular effects of H2S are mainly mediated through K
+
ATP-channel activation. Herein,
we compared the effects of D,L-propargylglycine (PAG), an inhibitor of H2S production, as well as sodium
hydrosulphide (NaHS), an H2S donor, on haemodynamics, vascular reactivity and cellular pathways in a rat model of I/R.
We also compared the haemodynamic effects of NaHS administered before and 10 minutes after reperfusion.
Methods: Mechanically ventilated and instrumented rats were bled during 60 minutes in order to maintain mean
arterial pressure at 40 ± 2 mmHg. Ten minutes prior to retransfusion, rats randomly received either an intravenous bolus
of NaHS (0.2 mg/kg) or vehicle (0.9% NaCl) or PAG (50 mg/kg). PNU, a pore-forming receptor inhibitor of K+ATP
channels, was used to assess the role of K+ATP channels.
Results: Shock and I/R induced a decrease in mean arterial pressure, lactic acidosis and ex vivo vascular
hyporeactivity, which were attenuated by NaHS administered before reperfusion and PNU but not by PAG and
NaHS administered 10 minutes after reperfusion. NaHS also prevented aortic inducible nitric oxide synthase
expression and nitric oxide production while increasing Akt and endothelial nitric oxide synthase phosphorylation.
NaHS reduced JNK activity and p-P38/P38 activation, suggesting a decrease in endothelial cell activation without
variation in ERK phosphorylation. PNU + NaHS increased mean arterial pressure when compared with NaHS or PNU
alone, suggesting a dual effect of NaHS on vascular reactivity.
Conclusion: NaHS when given before reperfusion protects against the effects of haemorrhage-induced I/R by
acting primarily through a decrease in both proinflammatory cytokines and inducible nitric oxide synthase
expression and an upregulation of the Akt/endothelial nitric oxide synthase pathway.
Keywords: hydrogen sulphide, inflammation mediators, therapeutic use, shock, hemorrhagic/drug therapy,
haemodynamics/drug effects
Introduction
The reperfusion phase of haemorrhagic shock is associated
with an inflammatory response, including increased NF-
B activation [1], increased inflammatory cytokine pro-
duction [2], increased nitric oxide (NO) production and
inducible nitric oxide synthase (iNOS) gene expression
[3,4], and increased activation of vascular K+ATP channels.
These inflammatory responses are associated with hypo-
tension, vasodilation and hyporesponsiveness to vasopres-
sor agents and lead to ischaemia-reperfusion (I/R) organ
injury [5]. Treating and/or preventing I/R-induced organ
injury is therefore a major challenge.
Hydrogen sulphide (H2S) is recognised as a gasotrans-
mitter, similar to NO and carbon monoxide. However,
current knowledge relative to its role in physiology and
pathology remains under discussion [6]. Many effects of
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H2S are the subject of controversy [7]. Depending on
the chosen models, H2S has been reported to display
opposite effects in haemorrhagic shock conditions.
While inhaled H2S and intravenous sodium sulphide
and sodium hydrosulphide (NaHS) reportedly increased
survival [8], improved haemodynamics, attenuated meta-
bolic failure in rodents [9-11], exerted cardioprotective
effects [10,11] as well as protected against organ injury
[12], sodium sulphide did not exert any beneficial effects
in swine [13]. Moreover, in other studies, blocking H2S
biosynthesis with D,L-propargylglycine (PAG), a
cystathionine g-lyase inhibitor, improved haemody-
namics and attenuated systemic inflammation and organ
injury [14,15].
The fact that H2S injection was associated with an
increase in arterial pressure is intriguing. Currently
available data indicate that H2S relaxes blood vessels
[16] mostly, if not exclusively, by opening ATP-regu-
lated potassium channels in vascular smooth muscle
cells [17,18]. We hypothesised that H2S injected at the
time of reperfusion could decrease the consequences of
shock and reperfusion, that the use of an inhibitor of
endogenous H2S production leads to opposite effects,
and that adding a vascular K+ATP-channel inhibitor
would improve the effects of H2S on systemic haemody-
namics. Using a previously published model of I/R
induced by haemorrhagic shock, we thus compared the
effects of H2S and of its inhibition as well as of K
+
ATP-
channel inhibition on haemodynamics, vascular reactiv-
ity and cellular pathways.
Materials and methods
The study protocol was approved by the Nancy Institu-
tional Committee on Animal Care and Use. The experi-
ments were performed in conformity with the European
legislation on the use of laboratory animals.
Animals
Adult male Wistar rats, weighing 325 ± 15 g, were
housed under 12-hour light/dark cycles in the animal
facility of the University of Nancy 1 (France).
Surgical procedure
Animals were anaesthetised with intraperitoneal pento-
barbital (50 mg/kg body weight). Rats were placed on a
homeothermic blanket system to maintain rectal tem-
perature between 36.8 and 37.8°C for the duration of the
experiment. After local anaesthesia with lidocaine 1%
(AstraZeneca, Rueil-Malmaison, France}), a tracheotomy
was performed and animals were mechanically ventilated
(Harvard Rodent 683 ventilator; Harvard Instruments,
South Natick, MA, USA) throughout the experiment.
The ventilator was set to maintain carbon dioxide partial
pressure in the vicinity of 40 mmHg and oxygen was
added in order to maintain oxygen partial pressure above
100 mmHg. The left carotid artery was exposed and a
2.0 mm transit-time ultrasound flow probe (Transonic
Systems Inc., Ithaca, NY, USA) was attached to the artery
to continuously measure carotid blood flow (CBF).
Under local anaesthesia, the femoral artery was canu-
lated in order to measure the mean arterial blood pres-
sure (MAP) and heart rate (HR) on the one hand, and
to induce haemorrhagic shock on the other. The homo-
lateral femoral vein was canulated for retransfusion of
withdrawn blood, for fluid replacement and for bolus
infusion of either vehicle or drugs.
Induction of haemorrhagic shock and protocol design
Surgery was followed by a 20-minute stabilisation per-
iod. Thereafter, haemorrhagic shock was induced by the
graded withdrawal of blood from the femoral artery to a
reservoir until MAP decreased to 40 mmHg and main-
tained during 60 minutes by further blood withdrawal
or reinfusion of shed blood. At 60 minutes, shed blood
was retransfused via the venous line within 10 minutes.
Animals were continuously monitored for HR, MAP
and CBF during 300 minutes. Hydration was performed
with a perfusion of 0.9% NaCl at a rate of 1.2 ml/hour.
At the end of the experiment, rats were sacrificed and
blood samples were collected for arterial lactate mea-
surement, centrifuged (4,000 rpm, 15 minutes, 4°C) and
plasma aliquoted and stored at -80°C until biochemical
analysis. Organs (aorta, heart and liver) were also col-
lected and stored at -80°C until biochemical analyses.
Pharmacological modulation
The dehydrated NaHS powder (anhydrous, 2 g; Alpha
Aesar GmbH & Co, Ward Hill, MA, USA) was dissolved
in isotonic saline under argon gas bubbling until a con-
centration of 40 mM was obtained and intravenously
administered as a single bolus (0.2 mg/kg body weight)
10 minutes before retransfusion or 10 minutes after the
end of retransfusion (late NaHS). PNU-37883A (guani-
dine; 4-morpholinecarboximidine-N-1-adamantyl-N’-
cyclohexyl hydrochloride) (Sigma Aldrich, St Quentin
Fallavier, France) was dissolved in a 1:1 mixture of
dimethyl sulphoxide and intravenously administered as a
bolus (1.5 mg/kg) followed by 1 mg/kg/hour. The induci-
ble NO synthase inhibitor 1400W (Sigma Aldrich) was
administered intraperitoneally (20 mg/kg) at T0.
Study design
Eight groups of eight rats were studied, namely: sham
rats, haemorrhagic shocked rats, shock + PAG (CSE inhi-
bitor)-treated rats (50 mg/kg), shock + NaHS-treated
rats, shock + late NaHS-treated rats, shock + PNU-
37883A-treated rats, shock + PNU + NaHS-treated rats,
and shock + 1400W-treated rats.
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Monitoring and measurements
Arterial blood gases were controlled after the stabilisa-
tion period, in order to establish mechanical ventilation.
Measurements of blood gas and blood glucose were
recorded at baseline (t = 0 minutes at the beginning of
haemorrhagic shock) and at two critical periods, namely
at the end of reperfusion (t = 70 minutes) and at the
end of the experiment (t = 300 minutes). MAP, HR,
CBF and rectal temperature were recorded at baseline
and every 10 minutes thereafter during the observation
period.
Lactate concentrations were determined using an
automated blood gas analyser (ABL5 Radiometer;
Neuilly-Plaisance, France).
Biochemical analyses
Plasma levels of IL-6 and TNFa were measured in
duplicate with the use of rat IL-6 and TNFa ELISA kits
(Quantikine ELISA; R&D Systems Europe, LILLE,
France) according to the manufacturer’s instructions.
Results were expressed as picograms of the measured
cytokine per millitre of plasma.
Measurement of nitrite/nitrate
NO2
- and NO3
- are the primary oxidised products of NO
reacting with water, and therefore the total concentration
of NO2
-/NO3
- in plasma was used as an indicator of NO
production in vivo. Briefly, the nitrate in the supernatant
was first reduced to nitrite by incubation with nitrate
reductase (10 U/ml) and NADPH (629.2 µg/ml) at room
temperature for 30 minutes. Thereafter, total nitrite con-
centration in the samples was measured by Griess reaction
following the addition of 100 µl Griess reagent to 100 µl
sample in a 96-well plate with a flat transparent bottom.
The optical density at 550 nm was measured by an ELISA
microplate reader and normalised with the optical density
at 550 nm of standard saline solutions.
RNA extraction and quantitative RT-PCR
Primers for quantitative RT-PCR were obtained from
Eurogentec (Angers, France). Total RNA extraction was
carried out with the RNA Plus mini kit (Qiagen, Courta-
boeuf Cedex, France) according to the manufacturer’s
instructions. Total RNA was reverse-transcribed to cDNA
using the iScript One-Step RT-PCR Kit for Probes (Biorad,
Marnes-la-Coquette, France). cDNA obtained from the RT
reaction was subjected to quantitative PCR using iTaq Fast
SYBR Green Supermix with ROX (Biorad, Marnes-la-
Coquette, France). The primer and concentrations were
optimised according to the manufacturer’s guidelines.
Expression of, Kir6.1 mRNA and SUR2B mRNA were
measured using iTaq Fast SYBR Green Supermix (Biorad).
The PCR reaction parameters were as follows: incuba-
tion at 50°C for 2 minutes, incubation at 95°C for
10 minutes, and thereafter 40 denaturation cycles at
95°C for 15 seconds and annealing and extension at 60°
C for 1 minute. Each sample was determined in dupli-
cate. To determine the relative mRNA levels, a standard
curve for each gene was created using RNA isolated
from the haemorrhagic shock group. Isolated RNA was
reverse-transcribed, and dilution series of cDNA ranging
from 1 pg to 10 ng were subjected to real-time PCR.
The obtained threshold cycle values were plotted against
the dilution factor to create a standard curve. Relative
mRNA levels in test samples were then calculated from
the standard curve.
Vascular reactivity
For in vivo determination, basal and maximal MAP
values obtained after administration of 1 µg/kg bolus of
norepinephrine were recorded in the sham, haemorrha-
gic shock, haemorrhagic shock + PNU and haemorrha-
gic shock + 1400W groups.
For ex vivo determination, aortic rings and small
mesenteric arteries were carefully dissected and
mounted on a wire myograph (Danish Myo Technology,
Arhus, Denmark). The experiments were performed at
37°C in a physiological salt solution with the following
composition: NaCl 119 mM; KCl 4.7 mM; NaHCO3
14.9 mM; MgSO4·7H2O 1.2 mM; CaCl2 2.5 mM;
KH2PO4 1.18 mM; glucose 5.5 mM, continuously
bubbled with 95% O2 and 5% CO2.
After an equilibration period (at least 20 minutes) under
optimal passive tension, two successive contractions
in response to the combination of KCl depolarisation
(100 mM) and phenylephrine (PE) (10 µM) (Sigma-
Aldrich) were used in order to test the maximal contractile
capacity of the vessels. After a 20-minute washout period,
concentration-response curves to PE were elicited by
cumulative administration of this vasoconstrictor agonist
(1 nM to 100 µM) in order to determine the same concen-
tration producing an equal level of contraction in the
different groups. To study endothelium-dependent relaxa-
tion, aortic rings with functional endothelium were pre-
contracted with PE (1 µM) and then exposed to increasing
incremental concentrations of acetylcholine (1 nM to
100 µM; Sigma, St Louis, MO, USA). The presence of
functional endothelium was confirmed with acetylcholine
(1 µM), which elicited a relaxation superior to 50%.
Western blotting
Aorta and small mesenteric arteries (200 to 230 μm) were
homogenised and lysed. Proteins (20 µg) were separated
on 10% SDS-PAGE. Blots were probed with the following
antibodies: anti-iNOS (BD Biosciences, San Jose, CA,
USA), phosphorylated endothelial nitric oxide synthase
(p-eNOS) (rabbit anti-rat eNOS, phosphorylated
(ser1177); Cell Signaling Technology Saint Quentin
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Yvelines, France), phosphorylated-Akt (p-Akt) (rabbit
anti-rat Akt, phosphorylated (ser473); Cell Signaling
Technology), phospho-SAPK/JNK (mouse, anti-rat
SAPK/JNK, phosphorylated (Thr183/Tyr185); Cell Sig-
naling Technology), phospho-p38 mitogen-activated pro-
tein kinase (mouse, anti-rat p38 MAPK, phosphorylated
(Thr180/Tyr182); Cell Signaling Technology), and phos-
phor-p44/42 MAPK (Erk1/2) (rabbit anti-rat p44/p42
MAPK, phosphorylated (Thr1202/Tyr204); Cell Signaling
Technology). Proteins were transferred onto nitrocellu-
lose membranes and probed with a monoclonal mouse
anti-a-Tubulin antibody (Sigma-Aldrich).
Bound antibodies were detected with a secondary per-
oxidase-conjugated anti-mouse IgG (Promega, Madison,
WI, USA). The blots were visualised using an enhanced
chemiluminescence system (ECL Plus; Amersham, GE
Healthcare Europe, Velizy-Villacoublay, France).
Statistical analyses
Results are expressed as the median and interquartile
range for n experiments (n representing the number of
animals). Difference between groups was tested using a
Kruskal-Wallis test. When the relevant F values were sig-
nificant at the 5% level, further pairwise comparisons were
performed using a Dunn’s multiple comparison test. All
statistics were performed with the Statview software (ver-
sion 5.0 software; SAS Institute, Cary, NC, USA). P < 0.05
was considered statistically significant.
Results
Model characterisation
Shock and I/R-induced hypotension, lactic acidosis and
vascular hyporeactivity to norepinephrine
The HR, MAP and CBF remained stable throughout the
experiment in the control group (Figure 1; see Additional
file 1). In animals subjected to haemorrhagic shock and
retransfusion, blood withdrawal significantly decreased the
MAP, HR and CBF (Figure 1; see Additional file 1).
Haemorrhagic shock was associated with a marked eleva-
tion in plasma lactate (9 × 2 mmol/l) compared with the
sham group (2.1 × 0.5 mmol/l) (see Additional file 2),
while the increase in arterial pressure induced by a bolus
of 1 µg/kg norepinephrine was significantly decreased (P <
0.01) in the shock group compared with sham animals
(Figure 2).
Ischaemia-reperfusion is associated with overexpression/
activation of iNOS and vascular K+ATP and increased
proinflammatory cytokines
IR-induced vascular hyporeactivity to a bolus of 1 µg/kg
norepinephrine was completely restored following the
administration of 1400W, a selective inhibitor of iNOS,
as well as PNU-37883A, a pore-forming receptor inhibi-
tor of K+ATP channels (Figure 2). I/R was associated with
an increase in aortic and mesenteric protein expression
Kir6.1 and SUR2B (Table 1). Plasma nitrite/nitrate
(NOx), TNFa and IL-6 were also increased in shock-only
rats (P < 0.05) (Figure 3).
Hemodynamic effects of NaHS administered 10 minutes
after the end of reperfusion
MAP, HR and CBF were not different when compared
between the late NaHS group and animals subjected to
haemorrhagic shock and retransfusion (Figure 4).
Comparative effects of NaHS and PAG
Hydrogen sulphide donor NaHS prevents I/R-induced
hemodynamic and metabolic dysfunction while PAG, an
inhibitor of endogenous H2S production, has no effects
NaHS but not PAG significantly attenuated the drop in
MAP induced by I/R (P < 0.05) (Figure 1) while CBF and
HR (data not shown) remained unaffected (Figure 1). All
animals treated with NaHS survived the haemorrhagic
shock, while haemorrhagic shocked rats and PAG-treated
rats had MAP < 40 mmHg (which we considered equiva-
lent to death) at the end of the experiment. Haemorrhagic
shock-induced hyperlactataemia was attenuated by NaHS
(HS-NaHS 5 × 2.3 mmol/l) (P < 0.05) but was not modi-
fied with PAG (P < 0.05) (see Additional file 2). Compared
with shock-only rats and shock + PAG rats, NaHS-treated
animals had a significantly improved pH (P < 0.05) at the
end of the experiment (T150) (see Additional file 2).
Sodium hydrosulphide improves vascular function in rat
aortic and small mesenteric vessels
PE induced a dose-dependent increase in tension in aortic
and small mesenteric vessels in control rats. In contrast,
haemorrhagic shock blunted PE-stimulated contraction
(P <0.01), whereas NaHS significantly restored the maximal
contractile capacity to control levels (P < 0.05) while PAG
had no effect (Figure 5A). Acetylcholine produced a con-
centration-dependent relaxation of isolated aortic and
small mesenteric vessels. Compared with the sham group,
vascular responses to acetylcholine decreased in the aorta
of shock-only rats (P < 0.05). The addition of NaHS
improved vascular response to acetylcholine while the inhi-
bitor PAG did not modify endothelial function (Figure 5B).
Effect of NaHS on inflammatory mediators in haemorrhagic
shock rats
Plasma nitrite/nitrate (NOx), TNFa and IL-6, which
were increased in shock-only, control rats (P < 0.05),
decreased in NaHS-treated rats (P < 0.05) and increased
in PAG-treated rats (P < 0.05) (Figure 3).
NaHS restores the phosphorylated Akt-to-Akt ratio and
phosphorylated eNOS-to-eNOS ratio, while reducing
haemorrhagic shock-induced upregulation of iNOS
expression
Expression levels of Akt and phosphorylated Akt (Akt
Ser473 phosphorylation) as well as phosphorylated Akt-
to-Akt ratio were decreased in the aorta of shock-only
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rats (Figure 6). NaHS treatment blunted this decrease
while PAG rather increased their expression levels (P <
0.05). Similar results were also found for phosphorylated
eNOS-to-eNOS ratio
The expression of iNOS protein, as assessed by wes-
tern blotting, increased in shock-only rats (compared
with rats from the sham group). This increase in iNOS
expression was significantly reduced following the
administration of NaHS (P < 0.05) but increased with
PAG (P < 0.05).
Effect of NaHS on alterations in p38 MAPK and JNK1/2
phosphorylation induced by haemorrhagic shock
NaHS reduced the phosphorylation of both p38 and JNK
(Figure 6D,E). Conversely, PAG increased this phosphory-
lation compared with NaHS. Neither PAG nor NaHS
influenced the phosphorylation of ERK (Figure 6F).
PNU-37883A, a pore-forming receptor inhibitor of K+ATP
channels, further increases the effects of NaHS
PNU-NaHS was associated with a further increase in
MAP when compared with NaHS alone (P < 0.05) (see
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Figure 1 Hemodynamic measurements. (A) Mean arterial blood pressure (MAP) and (B) carotid blood flow (CBF) in the sham (filled circles),
haemorrhagic shock + saline (crosses), haemorrhagic shock + sodium hydrosulphide (NaHS; triangles) and haemorrhagic shock + D,L-
propargylglycine (PAG; empty circles) groups recorded during a 300-minute monitoring period. *P <0.05, significantly different from sham. **P
<0.05 versus haemorrhagic shock + NaHS group.
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Additional file 3). PNU alone did not modify arterial pH
nor the lactate level, whereas PNU-NaHS was associated
with a decrease in lactate level and an increase in arter-
ial pH as opposed to no differences with NaHS alone
(P < 0.05) (data not shown).
Discussion
Herein, we illustrate the major role of NaHS in protect-
ing the body against the consequences of shock and I/R
[19]. Our findings revealed that the pharmacological inhi-
bition of the endogenous pathway of H2S production
during global I/R following a severe and reperfused hae-
morrhagic shock did not improve or worsen the conse-
quences of shock, suggesting that endogenous H2S
production per se is an active protective mechanism dur-
ing IR; and we confirm that NaHS, an exogenous donor
of H2S, is beneficial in terms of haemodynamics, tissue
oxygenation and vascular reactivity. The effects of NaHS
appear to be associated with a decrease in proinflamma-
tory cytokines and a reduced expression of iNOS conco-
mitant with a restoration of the eNOS pathway. These
beneficial effects of NaHS appear to be more related to
anti-inflammatory effects rather than to any specific vas-
cular effect secondary to vascular K+ATP activation since
selective inhibition of vascular K+ATP channels further
improved haemodynamics and lactate metabolism in
NaHS-treated rats. Furthermore, the effects of NaHS
were not due to NaHS-induced hibernation since the ani-
mal’s body temperature was continuously maintained.
Finally, H2S when given after reperfusion was not
efficient.
Our model was characterised by profound and ulti-
mately lethal hypotension, decreased blood flow, lactic
acidosis and vascular hyporesponsiveness to vasopressor
agents. These haemodynamic disturbances were asso-
ciated with iNOS upregulation, proinflammatory cyto-
kine production and activation/upregulation of vascular
K+ATP channels. The present findings confirmed that
H2S given prior to retransfusion limited the I/R-induced
decrease in MAP without changing carotid blood flow
and heart rate when compared with shock-only rats.
Given that H2S is usually considered an endogenous
vasodilator acting through activation of vascular K+ATP,
the role of this activation was further assessed with the
Figure 2 Mean arterial pressure after administration of norepinephrine. Mean arterial pressure (MAP) after administration of a bolus of
1 µg/kg norepinephrine in the haemorrhagic shock (HS) + saline, HS + 1400W (treated intraperitoneally with 1400W) and HS + PNU (treated
with a 1-hour infusion of PNU-37883A; 1.5 mg/kg bolus followed by 1 mg/kg/hour) groups. *P <0.05, significantly different between HS + saline
and all groups.
Table 1 mRNA expression of Kir6
Haemorrhagic shock
Kir6.1 Aorta 21 × 5*
Mesenteric 7 × 2*
SUR2B Aorta 12 × 7*
Mesenteric 3 × 0.3*
n = 7 in each group. *P < 0.05, significantly different between haemorrhagic
shock and sham groups.
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selective vascular K+ATP blocker, PNU-37883A. Our
results first demonstrated that K+ATP channels were over-
activated and overexpressed both at the gene and protein
levels in this model, indicating that vascular K+ATP is
implicated in vascular hyporesponsiveness to vasopressor
agents. Secondly, rats treated with H2S + PNU exhibited
a higher mean arterial pressure and a better vasoreactiv-
ity to norepinephrine. This may explain why H2S, which
Figure 3 Effects of sodium hydrosulphide and d,l-propargylglycine. Effects of sodium hydrosulphide (NaHS) and D,L-propargylglycine (PAG)
(50 mg/kg) on plasma levels of (A) nitrite + nitrate, (B) TNFa and (C) IL-6. Horizontal axes show the various groups. *P < 0.05, significantly
different between sham and all groups. **P < 0.05 versus haemorrhagic shock (HS) + NaHS group.
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Figure 4 Hemodynamic measurements with sodium hydrosulphide administered 10 minutes after the end of reperfusion. Mean arterial
blood pressure (MAP), carotid blood flow (CBF) and heart rate (HR) in sham (filled circles), haemorrhagic shock + saline (crosses), and
haemorrhagic shock + sodium hydrosulphide (NaHS) (triangles) groups recorded during a 300-minute monitoring period. *P <0.05, significantly
between sham.
Issa et al. Critical Care 2013, 17:R129
http://ccforum.com/content/17/4/R129
Page 8 of 12
is generally regarded as an endogenous vasodilator, para-
doxically increased MAP in this model. H2S probably
increases MAP through its well-demonstrated effects on
the inflammatory pathway on the one hand, while
decreasing MAP through K+ATP activation on the other,
with the global result being an increase in MAP [20].
Potassium channels are critical metabolic sensors during
acute metabolic changes such as hypoglycaemia or hyper-
glycaemia, ischaemia and hypoxia [21]. I/R-induced cardi-
ovascular failure is traditionally ascribed to the effects of
inflammatory mediators that induce circulatory changes
with resulting tissue hypoxia and cell damage [22]. In the
face of these deleterious signals, the body’s adaptive
response at the vascular level is to preserve cell survival
through metabolic sensors by increasing local blood flow
in the microcirculation, the so-called metabolic vasodilata-
tion, in which the opening of K+ATP channels plays a
major role [23]. This adaptive response also leads to sys-
temic vasodilatation, hypotension and potentially multiple
organ failure and death. Vascular potassium channels may
thus have protective but also harmful roles during shock.
Therefore, while the use of channel inhibitors might be an
attractive option to counteract systemic vasodilatation, it
may also act as a double-edged sword. Whether K+ATP
activation is a protective phenomenon in this setting of
disturbed microcirculation thus remains unknown.
Hydrogen sulphide and PAG exert opposite effects on
pathways implicated in vascular failure
Ganster and colleagues demonstrated that H2S improved
cardiovascular status in I/R by decreasing oxidative
stress and inflammation through a decrease in NF-B
activation [9]. Our present model was associated with
an increase in proinflammatory and anti-inflammatory
cytokines, an increase in iNOS expression and an altera-
tion in eNOS phosphorylation. As for the phosphoryla-
tion pathway, JNK phosphorylation was increased
without significant changes in the p-P38/P38 ratio.
Indeed, JNK and P38 have been shown to be activated
by TNF and IL-1 stimulation of endothelial cells [24]
Figure 5 Effects of treatment on phenylephrine-induced contraction in aorta and on aortic dilatation to acetylcholine. Effects of
treatment (A) on phenylephrine (Phe)-induced contraction in aorta and (B) on aortic dilatation to acetylcholine (ACh) in sham (filled squares),
haemorrhagic shock + saline (crosses), haemorrhagic shock + sodium hydrosulphide (triangles) and haemorrhagic shock + D,L-propargylglycine
(empty circles) groups. *P < 0.05.
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and to induce expression of proinflammatory effector
molecules.
In the present study, H2S was found to decrease the
cytokine storm as well as both gene and protein iNOS
expression while increasing Akt and eNOS phosphoryla-
tion. Moreover, H2S reduced JNK activity and p-P38/
P38 activation, suggesting a decrease in endothelial cell
activation [25]. Conversely, all of these parameters were
either not altered or worsened with PAG injection.
Study limitations
The present model presents several limitations, first of
which involves the use of a pressure-fixed and anaesthe-
tised model of haemorrhagic shock that does not fully
represent all of the specific patterns of human haemorrha-
gic shock.
Secondly, we used a fixed dose of NaHS that we pre-
viously found efficient without performing a dose-response
study, thus leaving the possibility that potentially toxic or
beneficial effects may have been missed.
Thirdly, we did not observe any differences between
the shock group and the PAG-treated group with regard
to haemodynamics, metabolism and proinflammatory
cytokine parameters. Van de Louw and Haouzi recently
demonstrated that, despite a severe cumulative oxygen
debt (100 to 140 ml/kg), H2S blood and tissue concen-
trations did not change [26]. Nevertheless, despite the
absence of a marked increase during H2S treatment,
blocking endogenous H2S production most probably has
little therapeutic benefit and may actually prove to be
contraindicated [27].
Fourthly, when compared with mouse and humans,
rats exhibited more iNOS activation during stress. The
importance of the H2S-induced decrease in iNOS activa-
tion should therefore be discussed.
Lastly, the timing of H2S administration might be dis-
cussed. While pretreatment with inhaled H2S and intra-
venous sodium sulphide attenuated kidney, heart, and
brain damage in mice undergoing I/R injury or cardiac
arrest [28,29], similar post-treatment had no effect
Figure 6 Western blot analysis of protein expression. Western blots revealing (A) inducible nitric oxide synthase (iNOS), (B) p-AKT,
(C) phosphorylated endothelial nitric oxide synthase (p-eNOS), (D) p-p38, (E) p-JNK and (F) p-ERK expression. Proteins are expressed in whole
lysates of aorta (n = 8) from all groups of rats. A typical western blot is shown below each histogram. Densitometric analysis was used to
calculate the normalised protein ratio (protein to a-tubulin), which was set at 1 for the control group. Data are expressed as mean ± standard
deviation. *P < 0.05, significantly different versus sham and all groups. **P <0.05 versus haemorrhagic shock (HS) + sodium hydrosulphide (NaHS)
group. PAG, D,L-propargylglycine.
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[12,30]. Our findings are in agreement with these pre-
vious reports suggesting that H2S beneficial effects seem
to be confined to a narrow timing window.
Conclusion
The present in vivo experimental study of I/R following
resuscitated haemorrhagic shock in rats demonstrates
that H2S administered exogenously before reperfusion is
protective against the deleterious cardiovascular effects
of haemorrhage-induced I/R. On the contrary, blocking
endogenous H2S production or administering H2S after
the reperfusion had no effect. More specifically, H2S
decreases proinflammatory cytokine and iNOS expres-
sion and restores the Akt/eNOS pathway. Such benefi-
cial effects of H2S donors warrant further experimental
studies.
Key messages
• H2S, administered exogenously before reperfusion is
protective against the deleterious cardiovascular effects
of haemorrhage-induced I/R.
• H2S is not effective when given after reperfusion.
• H2S increased MAP through anti-inflammatory
effects despite vasodilatory effects due to K+ATP-channel
activation.
• H2S decreases proinflammatory cytokine and iNOS
expression and restores the Akt/eNOS pathway.
Additional material
Additional file 1: Heart rate in sham (filled circles), haemorrhagic shock
+ saline (crosses), haemorrhagic shock + NaHS (triangles) and
haemorrhagic shock + PAG (empty circles) groups recorded during a
300-minute monitoring period. *P < 0.05.
Additional file 2: Metabolic parameters. Evolution of (A) lactate and
(B) pH. *P <0.05, significantly different versus sham group. **P <0.05
versus haemorrhagic shock + NaHS group.
Additional file 3: Hemodynamic measurements. MAP in the
haemorrhagic shock + saline group (crosses), haemorrhagic shock + PNU
(empty circles) group and haemorrhagic shock + PNU-NaHS (inversed
triangles) rats recorded during a 300-minute monitoring period. *P <0.05.
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